A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
PHASE3
Multiple myeloma (MM) is a plasma cell malignancy characterized by the prol...
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3
The purpose of this study is to compare the efficacy of teclistamab with PV...
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3
The purpose of this study is to compare the safety and efficacy of QLS32015...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases